Hydrophilic Polymer Drug from a Derivative of Salicylic Acid: Synthesis, Controlled Release Studies and Biological Behavior
- 17 June 2004
- journal article
- research article
- Published by Wiley in Macromolecular Bioscience
- Vol. 4 (6) , 579-586
Abstract
Summary: Hydrophilic polymeric drugs bearing “Triflusal” (4‐trifluoromethylsalicylic acid), a drug widely used as antithrombogenic agent (Disgren®), have been prepared by free radical copolymerization of methacryloyloxyethyl [2‐(acetyloxy)‐4‐(trifluoromethyl)] benzoate (HTRF) and N,N′‐dimethylacrylamide (DMA). The reactivity ratios of both monomers have been determined by 1H NMR spectra by applying non‐linear least square treatments to the copolymerization equation (terminal model), and the kinetic parameters obtained indicated that the microstructure of copolymer chains is homogeneous, with a random distribution of the active HTRF units along the copolymer chains. That means that for the copolymer system THDMA22 used in this work, HTRF units are mainly isolated in relatively long DMA sequences. Therefore, in this structure the intramolecular interactions between adjacent HTRF units are negligible. Release of Triflusal from THDMA22 has been studied in vitro using buffered solutions at pH = 2, 7.4 and 10 and 37 °C. The system showed an interesting pseudo‐zero order release profile at pH = 7.4 during several months. It has been also evaluated the pharmacological activity and the behavior of the system in contact with biological media. In this sense, we have carried out some in vitro studies about the antiaggregant properties and biocompatibility of THDMA22. Results demonstrate that this copolymer inhibits platelet aggregation in its macromolecular form and presents a good biocompatibility with Human Osteoblastic Cells (HOS). The Figure shows the drug release from THDMA22 at pH = 2 (⋄), 7.4 (□) and 10 (▵). magnified image The Figure shows the drug release from THDMA22 at pH = 2 (⋄), 7.4 (□) and 10 (▵).Keywords
This publication has 19 references indexed in Scilit:
- Vinylpyrrolidone–N,N′-dimethylacrylamide water-soluble copolymers: synthesis, physical–chemical properties and proteic interactionsBiomaterials, 2000
- Assessment of the Alamar Blue assay for cellular growth and viability in vitroJournal of Immunological Methods, 1997
- Characteristics of copolymerizations involving dimethylacrylamide and swelling behaviour of the copolymers in waterPolymer, 1996
- Effects of triflusal and its main metabolite HTB on platelet interaction with subendothelium in healthy volunteersEuropean Journal of Clinical Pharmacology, 1995
- Application of new coatings for vascular grafts based on polyacrylic systems with antiaggregating activityBiomaterials, 1994
- Chapter 11 Pharmacologic modification of materialsCardiovascular Pathology, 1993
- Effects and interaction studies of trifusal and other salicylic derivatives on cyclooxygenase in ratsProstaglandins, Leukotrienes and Essential Fatty Acids, 1988
- Effect of molecular weight (Mw) ofN‐(2‐hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsJournal of Biomedical Materials Research, 1987
- An improved method of calculating copolymerization reactivity ratiosJournal of Polymer Science Part A: General Papers, 1965
- Linear method for determining monomer reactivity ratios in copolymerizationJournal of Polymer Science, 1950